A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposome-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A new approach to the diagnosis and treatment of atherosclerosis: the era of the liposome

Published:2020-01 Issue:1 Volume:25 Page:58-72
ISSN:1359-6446
Container-title:Drug Discovery Today
language:en
Short-container-title:Drug Discovery Today

Author:

Kiaie Nasim,Gorabi Armita Mahdavi,Penson Peter E.,Watts Gerald,Johnston Thomas P.,Banach Maciej,Sahebkar Amirhossein

Funder

National Institute for Medical Research Development

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference123 articles.

1. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the interheart study): case-control study;Yusuf;Lancet,2004

2. Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel;Ference;Eur. Heart J.,2017

3. Inflammation in atherosclerosis;Libby;Nature,2002

4. Progress and challenges in translating the biology of atherosclerosis;Libby;Nature,2011

5. The nuclear factor-kappa B pathway in atherosclerosis: a potential therapeutic target for atherothrombotic vascular disease;Pamukcu;Thromb. Res.,2011

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoparticles as Drug Delivery Systems for the Targeted Treatment of Atherosclerosis;Molecules;2024-06-17

2. Magnetic nanoparticles and their hybrid biomaterials for drug delivery and theranostic applications in cardiovascular diseases;Journal of Drug Delivery Science and Technology;2024-06

3. Microfluidic-based cardiovascular systems for advanced study of atherosclerosis;Journal of Materials Chemistry B;2024

4. Foam Cell Targeted Liposomes Co-Encapsulating Superoxide Dismutase and Catalase to Attenuate Atherosclerosis by Inhibiting Oxidative Stress;Discovery Medicine;2024

5. Advances in nanobased platforms for cardiovascular diseases: Early diagnosis, imaging, treatment, and tissue engineering;Environmental Research;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3